Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Market capitalization change in key COVID-19 firms until end-May 2020

Gilead Sciences' market capitalization had increased by 26.3 billion U.S. dollars up to May 27, 2020. Gilead Sciences shot to the public spotlight due to trials of its drug remdesivir which is seen as a possible treatment for COVID-19.

Pharma companies involved in COVID-19 R&D with largest market capitalization change until May 27, 2020

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

May 2020

Region

Worldwide

Survey time period

as of May 27, 2020

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.